Epidemiological models for the spread of anti-malarial resistance

Malaria Journal

Volumn 2, Issue , 2003, Pages 1-11

  Koella, J C ^a   Antia, R ^b  

^a Laboratoire de Parasitologie Evolutive CNRS UMR 7103 UFR 927   (France)

^b EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; HOST; INFECTION RATE; MALARIA; MATHEMATICAL MODEL; MAXIMUM ALLOWABLE CONCENTRATION; PARASITE TRANSMISSION; RESISTANCE MANAGEMENT; SPATIAL AUTOCORRELATION ANALYSIS;

EID: 3042684521     PISSN: 14752875     EISSN: None     Source Type: Journal    
DOI: 10.1186/1475-2875-2-1     Document Type: Article

References (46)

1. Moore DV and Lanier JE Observations on two Plasmodium falciparum infections with abnormal response to chloroquine. Am J Trop Med Hyg 1961, 10:5-9
2. Hakim SL, Roohi SWAS, Zurkurnai Y, Rain AN, Mansor SM, Palmer K, Navaratnam V and Mak JW Plasmodium falciparum - increased proportion of severe resistance (RII and RIII) to chloroquine and high rate of resistance to sulfadoxine-pyrimethamine in peninsular Malaysia after 2 decades. Trans R Soc Trop Med Hyg 1996, 90:294-297
3. Smithius FM, Monti F, Grundl M, Oo AZ, Kyaw TT, Phe O and White MJ Plasmodium falciparum: sensitivity in vivo to chloroquine, pyrimethamine/sulfadoxine and mefloquine in western Myanmar. Trans R Soc Trop Med Hyg 1997, 91:468-472
4. Mockenhaupt F Mefloquine resistance in Plasmodium falciparum. Parasitol Today 1995, 11:248-253
5. Benito A, Roche J, Molina R, Amela C and Alvar J In vitro susceptibility of Plasmodium falciparum to chloroquine, amodiaquine, quinine, mefloquine, and sulfadoxine/pyrimethamine in Equatorial Guinea. Am J Trop Med Hyg 1995, 53:526-531
6. White NJ Delaying antimalarial drug resistance with combination chemotherapy. Parassitologia 1999, 41:301-8
7. White N Antimalarial drug resistance and combination chemotherapy. Phil Trans R Soc London B Biol Sci 1999, 354:739-49
8. Bonhoeffer S, Lipsitch M and Levin BR Evaluating treatment protocols to prevent antibiotic resistance. Proc Nat Acad Sci USA 1997, 94:12106-12111
9. Macdonald G The Epidemiology and Control of Malaria. London: Oxford University Press 1957
10. Dietz K, Molineaux L and Thomas A A malaria model tested in the African savannah. Bull Wrld Hlth Assoc 1974, 50:347-357
11. Molineaux L and Gramiccia G The Garki Project: Research on the Epidemiology and Control of Malaria in the Sudan Savanna of West Africa. Geneva: World Health Organization 1980
12. Halloran ME and Struchiner CJ Modeling transmission dynamics of stage-specific malaria vaccines. Parasitol Today 1992, 8:77-85
13. Gupta S and Anderson RM Predicting the effects of malaria vaccines on the population dynamics of infection and disease. In: Malaria Vaccine Development: A Multi-Immune Response Approach (Edited by: Hoffman SL) Washington DC: ASM Press 1996, S24-276
14. Curtis CF and Otoo LN A simple model of the build-up of resistance to mixtures of anti-malarial drugs. Trans R Soc Trop Med Hyg 1986, 80:889-892
15. Dye C and Williams BG Multigenic drug resistance among inbred malaria parasites. Proc R Soc London Ser B Biol Sci 1997, 264:61-67
16. Hastings IM A model for the origins and spread of drug resistant malaria. Parasitology 1997, 115:133-141
17. Aron JL Acquired immunity dependent upon exposure in an SIRS epidemic model. Math Biosc 1988, 88:37-47
18. Aron JL Mathematical modelling of immunity to malaria. Math Biosc 1988, 90:385-396
19. Boyd MF Epidemiology: factors related to the definitive host. In: Malariology. A Comprehensive Survey of All Aspects of This Group of Diseases from a Global Standpoint (Edited by: Boyd MF) Philadelphia: W.B. Saunders 1949, 1:608-697
20. Aron JL and May RM The population dynamics of malaria. In: The Population Dynamics of Infectious Diseases: Theory and Applications (Edited by: Anderson RM) London: Chapman and Hall 1982, 139-179
21. Nowak MA and May RM Superinfection and the evolution of parasite virulence. Proc R Soc London Ser B Biol Sci 1994, 255:81-89
22. Comins HN The development of insecticide resistance in the presence of migration. J theor Biol 1977, 64:177-197
23. Bremermann HJ and Thieme HR A competitive-exclusion principle for pathogen virulence. J math Biol 1989, 27:179-190
24. Wernsdorfer WH The development and spread of drug-resistant malaria. Parasitol Today 1991, 7:297-303
25. Kilombero Malaria Project Household based malaria control in a highly endemic area of Africa (Tanzania): determinants of transmission and disease and indicators for monitoring. Memorias do Instituto Oswaldo Cruz 1992, 87:121-130
26. Handunnetti SM, Gunewardena DM, Pathirana PPSL, Ekanayake K, Weerasinghe S and Mendis KN Features of recrudescent chloroquine-resistant Plasmodium falciparum infections confer a survival advantage on parasites and have implications for disease control. Trans R Soc Trop Med Hyg 1996, 90:563-567
27. Ichimori K, Curtis CF and Targett GAT The effects of chloroquine on the infectivity of chloroquine-sensitive and -resistant populations of Plasmodium yoelii nigeriensis to mosquitoes. Parasitology 1990, 100:377-381
28. Robert V, Molez J-F and Trape J-F Short report: gametocytes, chloroquine pressure, and the relative parasite survival advantage of resistant strains of falciparum malaria in West Africa. Am J Trop Med Hyg 1996, 55:350-351
29. Koella JC Linking evolutionary ecology with epidemiology. Rév Suisse Zool 1994, 101:865-874
30. Peters W Chemotherapy and Drug Resistance in Malaria. London: Academic Press 1987
31. Molineaux L The epidemiology of drug resistance in malaria: an unfinished conceptual model. WHO informal consultation on the epidemiology of drug resistance of malaria parasites 1986, Working paper 2.7.1:
32. Anderson RA, Knols BJG and Koella JC Plasmodium falciparum sporozoites increase feeding-associated mortality of their mosquito hosts Anopheles gambiae s.l. Parasitology 2000, 120:329-333
33. Klein TA, Harrison BA, Grove JS, Dixon SV and André RG Correlation of survival rates of Anopheles dirus A (Diptera: Culicidae) with different infection densities of Plasmodium cynomolgi. Bull Wrld Hlth Assoc 1986, 64:901-907
34. Anderson RM and May RM Infectious Diseases of Humans: Dynamics and Control. Oxford: Oxford University Press 1991
35. Koella JC On the use of mathematical models of malaria transmission. Acta Trop 1991, 49:1-25
36. Lipsitch M, Bergstrom CT and Levin BR The epidemiology of antibiotic resistance in hospitals: paradoxes and prescriptions. Proc Nat Acad Sci USA 2000, 97:1938-1943
37. Blower SM, Small PM and Hopewell PC Control strategies for tuberculosis epidemics: new models for old problems. Science 1996, 273:497-500
38. Blower SM, Aschenbach AN, Gershengorn HB and Kahn JO Predicting the unpredictable: transmission of drug-resistant HIV. Nat Med 2001, 7:1016-20
39. Mercado R, Vijh S, Allen SE, Kerksiek K, Pilip IM and Pamer EG Early programming of T cell populations responding to bacterial infection. J Immunol 2000, 165:6833-9
40. Gupta S, Maiden MCJ, Feavers IM, Nee S, May RM and Anderson RM The maintenance of strain structure in populations of recombining infectious agents. Nature Med 1996, 2:437-442
41. Tibayrenc M and Ayala FJ Towards a population genetic theory of micro-organisms: the clonal theory of parasitic protozoa. Parasitol Today 1991, 7:228-232
42. Cross AP and Singer B Modelling the development of resistance of Plasmodium falciparum to anti-malarial drugs. Trans R Soc Trop Med Hyg 1991, 85:349-355
43. Dye C Population genetics of nonclonal, nonrandomly mating malaria parasites. Parasitol Today 1991, 7:236-240
44. Dye C Models for investigating genetic exchange in protozoan populations. In: Modelling Vector-borne and Other Parasitic Diseases (Edited by: Perry BD, Hansen JW) Nairobi: ILRAD 1994, 165-176
45. Hastings IM and Mackinnon MJ The emergence of drug-resistant malaria. Parasitology 1998, 117:411-417
46. Clyde DF Malaria in Tanzania. Oxford: Oxford Univerity Press 1967